申请人:Otsuka Pharmaceutical Company, Limited
公开号:US04372953A1
公开(公告)日:1983-02-08
Tetrazole derivatives of the formula: ##STR1## wherein R.sup.1 is a lower alkykl, phenyl or a group of the formula: --S(O).sub.l --A--(X).sub.m --R.sup.3, and R.sup.2 is hydrogen, a lower alkyl, phenyl or a cycloalkyl when R.sup.1 is the group --S(O).sub.l --A--(X).sub.m --R.sup.3, or R.sup.2 is a group of the formula: --B--CO--R.sup.4 when R.sup.1 is a lower alkyl or phenyl and a pharmaceutically acceptable salt thereof, which have prophylactic or therapeutic activities against peptic and/or duodenal ulcers and are useful as an anti-ulcer drug; processes for the preparation of the tetrazole derivatives; and pharmaceutical composition containing said tetrazole derivatives.
Tetrazole衍生物的化学式为:##STR1## 其中R.sup.1是较低的烷基、苯基或化学式的基团:--S(O).sub.l --A--(X).sub.m --R.sup.3,而R.sup.2是氢、较低的烷基、苯基或环烷基,当R.sup.1是基团--S(O).sub.l --A--(X).sub.m --R.sup.3时,或者R.sup.2是化学式的基团:--B--CO--R.sup.4,当R.sup.1是较低的烷基或苯基时,以及其药学上可接受的盐,具有预防或治疗胃溃疡和/或十二指肠溃疡的活性,并可用作抗溃疡药物;制备Tetrazole衍生物的方法;以及含有上述Tetrazole衍生物的药物组合物。